-
Sep 3, 2024 | 
jamanetwork.com | Timothy Anderson |Deborah Grady
Glucagon-Like Peptide-1 Receptor Agonists and Suicidality—Two Important Pieces of Data but an Incomplete Puzzle GLP-1 Receptor Agonist Use and Risk of Suicide Death Peter Ueda, MD, PhD; Jonas Söderling, PhD; Viktor Wintzell, PhD; Henrik Svanström, PhD; Laura Pazzagli, PhD; Björn Eliasson, MD, PhD; Mads Melbye, MD, DrMedSci; Anders Hviid, DrMedSci; Björn Pasternak, MD, PhD Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology Thomas A. Wadden,...
-
Jun 10, 2024 | 
jamanetwork.com | Alison J. Huang |Deborah Grady
Recurrent urinary tract infection (rUTI) presents unique diagnostic and management dilemmas in older women in outpatient settings. Conventionally defined by symptomatic, culture-confirmed UTI occurring at least twice in 6 months or 3 times in a year, rUTI appears twice as common among women older than 65 years as in the general population of women.
-
Mar 18, 2024 | 
jamanetwork.com | Deborah Grady |Lona Mody
Hypertension Interventions for African American Patients in the Rural South Practice Facilitation and Peer Coaching for Uncontrolled Hypertension Among Black Individuals Monika M. Safford, MD; Doyle M. Cummings, PharmD; Jacqueline R. Halladay, MD, MPH; James M.
-
Jan 24, 2024 | 
jamanetwork.com | Deborah Grady |Sharon K. Inouye |Mitchell H. Katz
Access to Safe Abortion for Survivors of Rape The US Supreme Court’s decision in the Dobbs v Jackson Women’s Health Organization case allows individual states to determine access to abortion. Since the decision, 14 states have prohibited abortion at any gestational age. Restricting abortion access to survivors of rape can have particularly devastating consequences.
-
Jan 22, 2024 | 
jamanetwork.com | Deborah Grady
The Importance of Treating Opioid Use Disorder in Pregnancy First Trimester Use of Buprenorphine or Methadone and the Risk of Congenital Malformations Elizabeth A. Suarez, PhD, MPH; Brian T. Bateman, MD, MS; Loreen Straub, MD, MS; Sonia Hernández-Díaz, MD, DrPH; Hendrée E. Jones, PhD; Kathryn J. Gray, MD, PhD; Hilary S. Connery, MD, PhD; Jonathan M. Davis, MD; Barry Lester, PhD; Mishka Terplan, MD, MPH; Yanmin Zhu, PhD, MS; Seanna M. Vine, MPH; Helen Mogun, MS; Krista F.
-
Dec 26, 2023 | 
jamanetwork.com | Deborah Grady
Food for Thought—Include Controls in Policy Evaluations Food insecurity and poor diet may play a role in worsening many chronic diseases including diabetes, hypertension, and congestive heart failure. Thus, providing medically tailored meals or food as medicine for patients could be an effective and safe intervention.
-
Sep 5, 2023 | 
jamanetwork.com | Grace Zhang |Deborah Grady
Pharmacy e-Prescription Dispensing Before and After CancelRx Implementation Samantha I. Pitts, MD, MPH; Sarah Olson, MPH; Lisa R. Yanek, MPH; Nae-Yuh Wang, PhD, MS; Taylor Woodroof, PharmD, MS; Allen R.
-
Aug 14, 2023 | 
jamanetwork.com | Louise Aronson |Deborah Grady |Sharon K. Inouye
Introducing Inside Story, a New Section for JAMA Internal Medicine The importance of stories and storytelling in medicine and science should not be underestimated. While rigorous scientific evidence is central to advancing medicine and health care, the value of stories to comprehend, communicate, contextualize, and translate the evidence into practice and policy is vital.
-
Jul 31, 2023 | 
jamanetwork.com | Michael Incze |Deborah Grady |Sharon K. Inouye
Announcing Expanded Content for Clinicians Through the Clinical Review and Education Section at JAMA Internal Medicine At JAMA Internal Medicine, we are excited to announce new content that will promote our 4 core priorities (4Cs)—clinical relevance, clinical practice change, credibility, and effective and convincing communication. A major part of this effort is to expand our Clinical Review and Education section under the leadership of Michael Incze, MD, our new Section Editor.
-
Jul 17, 2023 | 
jamanetwork.com | Mitchell H. Katz |Deborah Grady
Opioid Dosing by Primary Care Professionals—A Call for Humility The 2016 Centers for Disease Control and Prevention (CDC) guidance for prescribing opioids for chronic pain recommended that clinicians should avoid increasing dosages to more than 90 morphine milligram equivalents per day because higher doses are associated with increased harms.1 The updated 2022 CDC guidelines do not recommend specific quantity thresholds but instead recommend shared decision-making.2 In their Viewpoint in this...
